
Sarae L. Bausch
Examiner (ID: 9546, Phone: (571)272-2912 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1699 |
| Total Applications | 1025 |
| Issued Applications | 192 |
| Pending Applications | 210 |
| Abandoned Applications | 650 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18077832
[patent_doc_number] => 20220403444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => PROXIMITY-DRIVEN ACTIVATION OF CRISPR-CAS SYSTEMS FOR DETECTION OF DIVERSE MOLECULAR ANALYTES
[patent_app_type] => utility
[patent_app_number] => 17/606225
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606225 | PROXIMITY-DRIVEN ACTIVATION OF CRISPR-CAS SYSTEMS FOR DETECTION OF DIVERSE MOLECULAR ANALYTES | Apr 26, 2020 | Pending |
Array
(
[id] => 17897347
[patent_doc_number] => 20220307009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => ISOLATED NUCLEIC ACID BINDING DOMAINS
[patent_app_type] => utility
[patent_app_number] => 17/594277
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594277
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594277 | ISOLATED NUCLEIC ACID BINDING DOMAINS | Apr 26, 2020 | Pending |
Array
(
[id] => 17642370
[patent_doc_number] => 20220170108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHOD FOR DIAGNOSING CANCER USING CFDNA
[patent_app_type] => utility
[patent_app_number] => 17/594063
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594063 | METHOD FOR DIAGNOSING CANCER USING CFDNA | Apr 2, 2020 | Pending |
Array
(
[id] => 17657512
[patent_doc_number] => 20220177977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => APPARATUS, SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/598324
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598324 | APPARATUS, SYSTEM AND METHOD | Mar 25, 2020 | Pending |
Array
(
[id] => 18198054
[patent_doc_number] => 20230051573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => METHODS AND KITS FOR DETECTING RHOA MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 17/441047
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441047 | METHODS AND KITS FOR DETECTING RHOA MUTATIONS | Mar 18, 2020 | Abandoned |
Array
(
[id] => 20386817
[patent_doc_number] => 12486536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => MicroRNA regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage
[patent_app_type] => utility
[patent_app_number] => 17/438288
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16700
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438288 | MicroRNA regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage | Mar 9, 2020 | Issued |
Array
(
[id] => 17564394
[patent_doc_number] => 20220128543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => MACROPHAGE MARKERS IN CANCER
[patent_app_type] => utility
[patent_app_number] => 17/436163
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436163 | MACROPHAGE MARKERS IN CANCER | Mar 5, 2020 | Abandoned |
Array
(
[id] => 18021076
[patent_doc_number] => 20220372575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => A KIT FOR DETECTION OF MUTATIONS CAUSING GENETIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/763340
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763340 | A KIT FOR DETECTION OF MUTATIONS CAUSING GENETIC DISORDERS | Mar 1, 2020 | Pending |
Array
(
[id] => 17595822
[patent_doc_number] => 20220145396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHOD OF IDENTIFYING PATIENTS WITH BORTEZOMIB RESISTANT MULTIPLE MYELOMA AND OTHER BLOOD DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/436117
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436117
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436117 | METHOD OF IDENTIFYING PATIENTS WITH BORTEZOMIB RESISTANT MULTIPLE MYELOMA AND OTHER BLOOD DISEASES | Feb 27, 2020 | Abandoned |
Array
(
[id] => 17563532
[patent_doc_number] => 20220127681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => SORTING CELL-TYPE SPECIFIC EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/434558
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434558
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434558 | SORTING CELL-TYPE SPECIFIC EXTRACELLULAR VESICLES | Feb 26, 2020 | Abandoned |
Array
(
[id] => 17482705
[patent_doc_number] => 20220090209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => RETROTRANSPOSON BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 17/430873
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430873 | RETROTRANSPOSON BIOMARKERS | Feb 12, 2020 | Abandoned |
Array
(
[id] => 16238674
[patent_doc_number] => 20200255908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA
[patent_app_type] => utility
[patent_app_number] => 16/786780
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786780 | Genes and gene signatures for diagnosis and treatment of melanoma | Feb 9, 2020 | Issued |
Array
(
[id] => 17564416
[patent_doc_number] => 20220128565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => ANALYTE DETECTION BY SELECTIVE LABELING OF BIOLOGICAL SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/428410
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428410 | ANALYTE DETECTION BY SELECTIVE LABELING OF BIOLOGICAL SAMPLES | Feb 3, 2020 | Pending |
Array
(
[id] => 17595821
[patent_doc_number] => 20220145395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Transpochimeric Gene Transcripts (TCGTS) As Cancer Biomarkers
[patent_app_type] => utility
[patent_app_number] => 17/419990
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17419990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/419990 | Transpochimeric Gene Transcripts (TCGTS) As Cancer Biomarkers | Jan 2, 2020 | Pending |
Array
(
[id] => 17750020
[patent_doc_number] => 20220228225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SNP MARKER COMBINATION AND IDENTIFICATION METHOD FOR PUDONG WHITE PIGS AND RAW MEAT PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/042122
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042122
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042122 | SNP MARKER COMBINATION AND IDENTIFICATION METHOD FOR PUDONG WHITE PIGS AND RAW MEAT PRODUCTS | Dec 30, 2019 | Abandoned |
Array
(
[id] => 16091395
[patent_doc_number] => 20200199684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => METHOD FOR PROGNOSIS OF RENAL CELL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 16/708879
[patent_app_country] => US
[patent_app_date] => 2019-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/708879 | METHOD FOR PROGNOSIS OF RENAL CELL CARCINOMA | Dec 9, 2019 | Abandoned |
Array
(
[id] => 17370414
[patent_doc_number] => 20220025466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => DIFFERENTIAL METHYLATION
[patent_app_type] => utility
[patent_app_number] => 17/309348
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309348
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309348 | DIFFERENTIAL METHYLATION | Nov 28, 2019 | Pending |
Array
(
[id] => 17357171
[patent_doc_number] => 20220017967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => MOLECULAR SIGNATURE
[patent_app_type] => utility
[patent_app_number] => 17/309349
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309349 | MOLECULAR SIGNATURE | Nov 28, 2019 | Pending |
Array
(
[id] => 17642372
[patent_doc_number] => 20220170110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => CANCER DIAGNOSTIC MARKER USING TRANSPOSASE-ACCESSIBLE CHROMATIN SEQUENCING INFORMATION ABOUT INDIVIDUAL, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/601332
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601332 | CANCER DIAGNOSTIC MARKER USING TRANSPOSASE-ACCESSIBLE CHROMATIN SEQUENCING INFORMATION ABOUT INDIVIDUAL, AND USE THEREOF | Nov 18, 2019 | Abandoned |
Array
(
[id] => 18264494
[patent_doc_number] => 20230085736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => PRIMER FOR DETECTING FECAL POLLUTION IN WATER, KIT AND HIGH-THROUGHPUT TRACING METHOD
[patent_app_type] => utility
[patent_app_number] => 16/958737
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958737
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958737 | PRIMER FOR DETECTING FECAL POLLUTION IN WATER, KIT AND HIGH-THROUGHPUT TRACING METHOD | Nov 14, 2019 | Abandoned |